• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cardiovasc Res . Sex differences and disparities in cardiovascular outcomes of COVID-19

tetano

Editor, Senior Moderator
Cardiovasc Res


. 2023 Jan 18;cvad011.
doi: 10.1093/cvr/cvad011. Online ahead of print.
Sex differences and disparities in cardiovascular outcomes of COVID-19


Raffaele Bugiardini[SUP] 1 [/SUP], Stefano Nava[SUP] 1 2 [/SUP], Gaetano Caramori[SUP] 3 [/SUP], Jinsung Yoon[SUP] 4 [/SUP], Lina Badimon[SUP] 5 [/SUP], Maria Bergami[SUP] 1 [/SUP], Edina Cenko[SUP] 1 [/SUP], Antonio David[SUP] 6 [/SUP], Ilir Demiri[SUP] 7 [/SUP], Maria Dorobantu[SUP] 8 [/SUP], Oana Fronea[SUP] 8 [/SUP], Radmilo Jankovic[SUP] 9 [/SUP], Sasko Kedev[SUP] 10 [/SUP], Nebojsa Ladjevic[SUP] 11 [/SUP], Ratko Lasica[SUP] 12 [/SUP], Goran Loncar[SUP] 13 [/SUP], Giuseppe Mancuso[SUP] 14 [/SUP], Guiomar Mendieta[SUP] 15 [/SUP], Davor Miličić[SUP] 16 [/SUP], Petra Mjehović[SUP] 16 [/SUP], Marijan Pašalić[SUP] 16 [/SUP], Milovan Petrović[SUP] 17 [/SUP], Lidija Poposka[SUP] 10 [/SUP], Marialuisa Scarpone[SUP] 1 [/SUP], Milena Stefanovic[SUP] 7 [/SUP], Mihaela van der Schaar[SUP] 18 19 [/SUP], Zorana Vasiljevic[SUP] 20 [/SUP], Marija Vavlukis[SUP] 10 [/SUP], Maria Laura Vega Pittao[SUP] 1 [/SUP], Vladan Vukomanovic[SUP] 21 [/SUP], Marija Zdravkovic[SUP] 22 [/SUP], Olivia Manfrini[SUP] 1 [/SUP]



Affiliations

Abstract

Background: Previous analyses on sex differences in case fatality rates at population-level data had limited adjustment for key patient clinical characteristics thought to be associated with COVID-19 outcomes. We aimed to estimate the risk of specific organ dysfunctions and mortality in women and men.
Methods and results: This retrospective cross-sectional study included 17 hospitals within 5 European countries participating in the International Survey of Acute Coronavirus Syndromes (ISACS) COVID-19(NCT05188612). Participants were individuals hospitalized with positive SARS-CoV-2 from March 2020 to February 2022. Risk-adjusted ratios(RR) of in-hospital mortality, acute respiratory failure(ARF), acute heart failure(AHF), and acute kidney injury(AKI) were calculated for women versus men. Estimates were evaluated by inverse probability of weighting and logistic regression models. The overall care cohort included 4,499 patients with COVID-19 associated hospitalizations. Of these, 1,524(33.9%) were admitted to ICU, and 1,117(24.8%) died during hospitalization. Compared with men, women were less likely to be admitted to ICU (RR:0.80; 95%CI: 0.71-0.91). In general wards (GW) and ICU cohorts, the adjusted women-to-men RRs for in-hospital mortality were of 1.13(95%CI: 0.90-1.42) and 0.86(95%CI: 0.70-1.05; pinteraction=0.04). Development of AHF, AKI and ARF was associated with increased mortality risk (ORs: 2.27; 95%CI; 1.73-2.98,3.85; 95%CI:3.21-4.63 and 3.95; 95%CI:3.04-5.14, respectively). The adjusted RRs for AKI and ARF were comparable among women and men regardless of intensity of care. By contrast, female sex was associated with higher odds for AHF in GW, but not in ICU (RRs:1.25; 95%CI0.94-1.67 versus 0.83; 95%CI:0.59-1.16, pinteraction=0.04).
Conclusions: Women in GW were at increased risk of AHF and in-hospital mortality for COVID-19 compared with men. For patients receiving ICU care, fatal complications including AHF and mortality appeared to be independent of sex. Equitable access to COVID-19 ICU care is needed to minimize the unfavourable outcome of women presenting with COVID-19 related complications.

Keywords: COVID-19; acute heart failure; acute kidney injury; acute respiratory failure; mortality; sex; women.
 
Back
Top Bottom